The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: A double blind, randomized, placebo controlled trial

Dorit Pud, Elon Eisenberg, Ada Spitzer, Rivka Adler, Georgetta Fried, David Yarnitsky

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: A double blind, randomized, placebo controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences